Our findings suggest that treating cells with MEK-inhibitor prior to infection increases CAR expression, arrests cells in G1 cell cycle phase, and sensitizes cells to infection such that we observe reduced viability and improved virus replication. The gene discussed is MAP2K7; the disease is infection.